Literature DB >> 17238187

High levels of CXCL8 in tracheal aspirate samples taken at birth are associated with adverse respiratory outcome only in preterm infants younger than 28 weeks gestation.

Jozef De Dooy1, Margareta Ieven, Wim Stevens, Luc De Clerck, Ludo Mahieu.   

Abstract

We investigated the relation between perinatal endotracheal colonization, the associated cytokine response and respiratory outcome in ventilated preterm neonates. Between September 1999 and March 2002, a cohort of 141 neonates with a gestational age <31 weeks requiring ventilation directly after birth, were followed prospectively. All were admitted to the Neonatal Intensive Care Unit, University Hospital of Antwerp, Belgium. A tracheal aspirate (TA) sample was collected soon after birth and was processed for microbiological examination, leukocyte count, and cytokine analysis (interleukins [IL] IL-1beta, IL-6, CXCL8 (formerly called IL-8), IL-10, IL-12p70 and tumor necrosis factor alpha [TNF-alpha]). Together with the prospectively registered patient's comorbidities and severity of disease, these inflammatory parameters were analyzed in a multivariate Cox proportional hazards model with time of extubation and duration of oxygen therapy as main outcome measures. Of the 141 patients included, 31 (22%) died before discharge from the unit and 37 (26%) had a positive TA culture. Independent predictors of duration of mechanical ventilation were: gestational age <28 weeks, degree of respiratory distress syndrome (RDS) at birth, significant patent ductus arteriosus (PDA), the SNAP-score, and high levels of CXCL8 (>4,153 pg/ml) in TA only in neonates with a gestational age <28 weeks. Variables associated with extended duration of oxygen therapy were gestational age <28 weeks, birth weight <1,000 g, degree of RDS at birth, and duration of mechanical ventilation. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17238187     DOI: 10.1002/ppul.20511

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  6 in total

1.  Microarray gene expression analysis in ovine ductus arteriosus during fetal development and birth transition.

Authors:  Ravi Goyal; Dipali Goyal; Lawrence D Longo; Ronald I Clyman
Journal:  Pediatr Res       Date:  2016-06-03       Impact factor: 3.756

Review 2.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

3.  Role of serine proteases in the regulation of interleukin-877 during the development of bronchopulmonary dysplasia in preterm ventilated infants.

Authors:  Mallinath Chakraborty; Eamon P McGreal; Andrew Williams; Philip L Davies; Wendy Powell; Salima Abdulla; Nikolai N Voitenok; John Hogwood; Elaine Gray; Brad Spiller; Rachel C Chambers; Sailesh Kotecha
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

4.  Inflammatory and oxidative stress airway markers in premature newborns of hypertensive mothers.

Authors:  R J Madoglio; L M S S Rugolo; C S Kurokawa; M P A Sá; J C Lyra; L C O Antunes
Journal:  Braz J Med Biol Res       Date:  2016-08-01       Impact factor: 2.590

5.  Innate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation.

Authors:  Katheryn E Nathe; Christy J Mancuso; Richard Parad; Linda J Van Marter; Camilia R Martin; Liat Stoler-Barak; Victoria J Philbin; Michele F Phillips; Christine D Palmer; Ofer Levy
Journal:  Pediatr Res       Date:  2012-08       Impact factor: 3.756

6.  Pulmonary Biomarkers of Bronchopulmonary Dysplasia.

Authors:  Alecia Thompson; Vineet Bhandari
Journal:  Biomark Insights       Date:  2008-07-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.